ADIL — Adial Pharmaceuticals Share News
0.000.00%
Last trade - 00:00Brief: Adial Pharmaceuticals Announces Planned Appointment Of Celia Economides As Chief Financial Officer
Brief: Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Adial Pharmaceuticals - Proposed Resale Of Up To 25,148,970 Shares Of Common Stock By Selling Stockholders - SEC Filing
Brief: Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
U.S. STOCKS ON THE MOVE - Nvidia, Gold miners, Nike
U.S. STOCKS ON THE MOVE - Sunrun, JetBlue Airways, Dell Technologies
U.S. STOCKS ON THE MOVE - KBR, Vista Energy, Fulcrum Therapeutics
Adial Pharmaceuticals falls after quarterly loss widens
Adial Pharmaceuticals posts bigger-than-expected Q2 net loss, hurt by acquisition charges
Adial Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Adial Pharmaceuticals - As Of Aug 10, Anticipates Termination Of CEO Cary Claiborne After 2026 Annual Meeting
Adial Pharmaceuticals Inc expected to post a loss of $1.03 a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina
Brief: Adial Pharmaceuticals Expands Executive Leadership Team And Closes Pipe Financing
Brief: Adial Pharmaceuticals Announces Acquisition Of Azora Therapeutics And Up To $64 Million Financing
NASDAQ RESUMED AT 12:48 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:43 PM
NASDAQ RESUMED AT 12:26 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:44 AM